Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Capital Expenditures (2021 - 2025)

P3 Health Partners' Capital Expenditures history spans 4 years, with the latest figure at -$198000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures changed N/A year-over-year to -$198000.0; the TTM value through Dec 2025 reached -$198000.0, changed N/A, while the annual FY2025 figure was -$79000.0, N/A changed from the prior year.
  • Capital Expenditures reached -$198000.0 in Q4 2025 per PIIIW's latest filing, up from -$212000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.2 million in Q2 2021 to a low of -$212000.0 in Q4 2023.
  • Average Capital Expenditures over 4 years is $550153.8, with a median of $524000.0 recorded in 2022.
  • The largest YoY upside for Capital Expenditures was 126.72% in 2023 against a maximum downside of 324.0% in 2023.
  • A 4-year view of Capital Expenditures shows it stood at $299870.0 in 2021, then tumbled by 116.67% to -$50000.0 in 2022, then crashed by 324.0% to -$212000.0 in 2023, then grew by 6.6% to -$198000.0 in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Capital Expenditures are -$198000.0 (Q4 2025), -$212000.0 (Q4 2023), and $387000.0 (Q3 2023).